Transcranial Magnetic Stimulation No Better Than Placebo for Treatment-Resistant Depression
A new study in JAMA Psychiatry found that transcranial magnetic stimulation was no better than placebo for treatment-resistant depression.
Adverse Effects: The Perils of Deep Brain Stimulation for Depression
Hundreds of people have been given remote control deep brain stimulation implants for psychiatric disorders such as depression, OCD and Touretteâs. Yet DBS specialists still have no clue about its mechanisms of action and research suggests its hefty health and safety risks far outweigh benefits.
Study Finds Hearing Voices Groups Improve Social and Emotional Wellbeing
Hearing Voices Network self-help groups are an important resource for coping with voice hearing, study finds.
Antidepressants Do Not Prevent Suicides, May Increase Risk
When the CDC released data revealing an increasing suicide rate in the US, some experts, speaking to major media outlets, speculated that the increase...
Mental Health Concerns Not âBrain Disorders,â Say Researchers
The latest issue of the journal Behavioral and Brain Sciences features several prominent researchers arguing that mental health concerns are not âbrain disorders.â
Researchers Set the Record Straight on Controversial Zoloft Study
An issue of Lancet Psychiatry is devoted to clarifying the lack of efficacy for Zoloft (sertraline).
What Does Social Justice Really Mean for Psychologists?
Without clarity and consensus around what social justice means, psychologists risk perpetuating injustices that undermine their stated mission.
Very Slow Tapering Best For Antidepressant Withdrawal
A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.
Fighting for the Meaning of Madness: An Interview with Dr. John Read
Akansha Vaswani interviews Dr. John Read about the influences on his work and his research on madness, psychosis, and the mental health industry.
Treating Metabolic Conditions May Resolve Some Depressive Symptoms
New research suggests that treatable metabolic abnormalities underlie some treatment-resistant cases of depressionâand treating the metabolic condition has the possibility of dramatically reducing depressive symptoms
New Study Concludes that Antidepressants are “Largely Ineffective and Potentially Harmfulâ
A new study published in Frontiers in Psychiatry concludes that âantidepressants are largely ineffective and potentially harmful.â
Multiple Researchers Examining the Same Data Find Very Different Results
A new study demonstrates how the choice of statistical techniques when examining data plays a large role in scientific outcomes.
Researchers Expose Pharmaceutical Industry Misconduct and Corruption
Corruption of pharmaceutical industry sponsored clinical trials identified as a âmajor obstacleâ facing evidence-based medicine.
United Nations Report Calls for Revolution in Mental Health Care
In a new report, the United Nations Special Rapporteur on the right to health, Dr. Dainius PĆ«ras, calls for a move away from the biomedical model and âexcessive use of psychotropic medicines.â
The Conflicts That Result From Globalizing Euro-American Psychology in India
Researchers examine the transformation of work, life, and identity in India as a result of Western corporate and psychological culture.
How Dissenting Voices are Silenced in Medicine
Researcher criticizes the many ways opposing viewpoints and dissenting voices are squashed in the field of medicine.
New Data Show Lack of Efficacy for Antidepressants
An article published this month in the journal BMC Psychiatry suggests that there is a lack of efficacy for SSRIs and that they significantly increase the risk of serious side effects.
First-Person Accounts of Madness and Global Mental Health: An Interview with Dr. Gail Hornstein
Dr. Gail Hornstein, author of Agnesâs Jacket: A Psychologistâs Search for the Meanings of Madness, discusses the importance of personal narratives and service-user activism in the context of the global mental health movement.
Better Outcomes Off Medication for Those Recovered from First-Episode Schizophrenia
A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioningâand reached full recovery more quickly.
Psychosocial Explanations of Psychosis Reduce Stigma, Study Finds
A review of mental health anti-stigma campaigns finds psychosocial models are effective in reducing stigma, while biogenetic models often worsen attitudes.
Withdrawal Symptoms Routinely Confound Findings of Psychiatric Drug Studies
Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.
Anti-Stigma Campaigns Enable Inequality, Sociologists Argue
Scholars contend that stigma functions as a mechanism of power in analysis of UK Heads Together mental health campaign.
Researchers Find Bias in Industry-Funded Continuing Medical Education
Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.
SNRIs Added to the List of Drugs with Potential Withdrawal Symptoms
New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.
Different Forms of Childhood Adversity Related to Specific Psychosis Symptoms
In this monthâs issue of Psychological Medicine, researchers from Kingâs College London found evidence for associations between different types of childhood adversity and specific symptoms associated with psychosis. As current categorical approaches to psychosis and schizophrenia diagnoses come under increasing scrutiny, this study adds support to sociological and psychological theories and treatments.